SB Investment Advisers (uk) Ltd., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 548,902 shares at $25.84 ($14.5M) on 2023-05-23, disclosed to the SEC on 2023-05-25.
Open-market sale of $14.5M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.84 | 2,317 | $60K | 0.4% |
| 2 | $25.84 | 2,317 | $60K | 0.4% |
| 3 | $26.61 | 144,402 | $3.8M | 26.5% |
| 4 | $26.61 | 144,402 | $3.8M | 26.5% |
| 5 | $27.02 | 23,348 | $631K | 4.3% |
| 6 | $27.02 | 23,348 |
| $631K |
| 4.3% |
| 7 | $25.89 | 35,307 | $914K | 6.3% |
| 8 | $25.89 | 35,307 | $914K | 6.3% |
| 9 | $26.25 | 66,754 | $1.8M | 12.1% |
| 10 | $26.25 | 66,754 | $1.8M | 12.1% |
| 11 | $27.12 | 2,323 | $63K | 0.4% |
| 12 | $27.12 | 2,323 | $63K | 0.4% |
| Total | $26.46 avg | 548,902 | $14.5M | 100% |
| Filing → |
| VIR | SELL | 2025-10-24 | $3.6M | — | Filing → |
| VIR | SELL | 2025-10-09 | $6.4M | — | Filing → |
| CPNG | SELL | 2025-06-17 | $282.5M | — | Filing → |